Zacks Investment Research upgraded shares of Myomo (NYSEAMERICAN:MYO – Get Rating) from a sell rating to a hold rating in a research report report published on Tuesday, Zacks.com reports. According to Zacks, “Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The […]